{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T13:59:38Z","timestamp":1792159178273,"version":"4.4.0"},"reference-count":226,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T00:00:00Z","timestamp":1629244800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008335","name":"Arizona Biomedical Research Commission","doi-asserted-by":"publisher","award":["ADHS18-198859"],"award-info":[{"award-number":["ADHS18-198859"]}],"id":[{"id":"10.13039\/100008335","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008335","name":"Arizona Biomedical Research Commission","doi-asserted-by":"publisher","award":["T32 GM008804"],"award-info":[{"award-number":["T32 GM008804"]}],"id":[{"id":"10.13039\/100008335","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI147325"],"award-info":[{"award-number":["AI147325"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI157046"],"award-info":[{"award-number":["AI157046"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.apsb.2021.08.017","type":"journal-article","created":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T12:00:38Z","timestamp":1629460838000},"page":"1542-1566","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":99,"title":["Enterovirus A71 antivirals: Past, present, and future"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4845-4621","authenticated-orcid":false,"given":"Jun","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanmei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9922-2938","authenticated-orcid":false,"given":"Madeleine","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2021.08.017_bib1","first-page":"43","article-title":"Picornaviruses","volume":"343","author":"Tuthill","year":"2010","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.apsb.2021.08.017_bib2","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/MOP.0000000000000303","article-title":"Enteroviruses in the early 21st century: new manifestations and challenges","volume":"28","author":"Lugo","year":"2016","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.apsb.2021.08.017_bib3","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S1474-4422(10)70209-X","article-title":"Clinical features, diagnosis, and management of enterovirus 71","volume":"9","author":"Ooi","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.apsb.2021.08.017_bib4","doi-asserted-by":"crossref","first-page":"103115","DOI":"10.1016\/j.ebiom.2020.103115","article-title":"Hand foot and mouth disease: enteroviral load and disease severity","volume":"62","author":"Tyring","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.apsb.2021.08.017_bib5","article-title":"Modelling person-to-person transmission in an enterovirus A71 orally infected hamster model of hand-foot-and-mouth disease and encephalomyelitis","volume":"6","author":"Phyu","year":"2017","journal-title":"Emerg Microb Infect"},{"key":"10.1016\/j.apsb.2021.08.017_bib6","doi-asserted-by":"crossref","first-page":"e2552","DOI":"10.1093\/cid\/ciaa1853","article-title":"Basic reproduction number of enterovirus 71 coxsackievirus A16 and A6: evidence from outbreaks of hand, foot and mouth disease in China between 2011 and 2018","volume":"73","author":"Zhang","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.apsb.2021.08.017_bib7","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/1743-422X-10-222","article-title":"Genetic characterization of EV71 isolates from 2004 to 2010 reveals predominance and persistent circulation of the newly proposed genotype D and recent emergence of a distinct lineage of subgenotype C2 in Hong Kong","volume":"10","author":"Yip","year":"2013","journal-title":"Virol J"},{"key":"10.1016\/j.apsb.2021.08.017_bib8","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S1473-3099(10)70194-8","article-title":"Virology, epidemiology, pathogenesis, and control of enterovirus 71","volume":"10","author":"Solomon","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.apsb.2021.08.017_bib9","doi-asserted-by":"crossref","first-page":"11662","DOI":"10.1038\/s41598-019-48259-1","article-title":"The clinical and epidemiological study of children with hand, foot, and mouth disease in Hunan, China from 2013 to 2017","volume":"9","author":"Qiu","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2021.08.017_bib10","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12929-019-0573-2","article-title":"The history of enterovirus A71 outbreaks and molecular epidemiology in the Asia-Pacific region","volume":"26","author":"Puenpa","year":"2019","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.apsb.2021.08.017_bib11","doi-asserted-by":"crossref","first-page":"103078","DOI":"10.1016\/j.ebiom.2020.103078","article-title":"Enterovirus genomic load and disease severity among children hospitalised with hand, foot and mouth disease","volume":"62","author":"Song","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.apsb.2021.08.017_bib12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12929-019-0552-7","article-title":"Enterovirus A71 neurologic complications and long-term sequelae","volume":"26","author":"Chang","year":"2019","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.apsb.2021.08.017_bib13","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S1473-3099(19)30632-2","article-title":"Clinical characteristics of enterovirus A71 neurological disease during an outbreak in children in Colorado, USA, in 2018: an observational cohort study","volume":"20","author":"Messacar","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.apsb.2021.08.017_bib14","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/NEN.0b013e31817713e7","article-title":"Pathologic characterization of a murine model of human enterovirus 71 encephalomyelitis","volume":"67","author":"Ong","year":"2008","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.apsb.2021.08.017_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2082","article-title":"Global epidemiology of nonpolio enteroviruses causing severe neurological complications: a systematic review and meta-analysis","volume":"30","author":"Suresh","year":"2020","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.apsb.2021.08.017_bib16","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/bpa.12279","article-title":"Understanding enterovirus 71 neuropathogenesis and its impact on other neurotropic enteroviruses","volume":"25","author":"Ong","year":"2015","journal-title":"Brain Pathol"},{"key":"10.1016\/j.apsb.2021.08.017_bib17","doi-asserted-by":"crossref","first-page":"23444","DOI":"10.1038\/srep23444","article-title":"Neurological complications and risk factors of cardiopulmonary failure of EV-A71-related hand, foot and mouth disease","volume":"6","author":"Long","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2021.08.017_bib18","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.pathol.2015.12.450","article-title":"Pulmonary and central nervous system pathology in fatal cases of hand foot and mouth disease caused by enterovirus A71 infection","volume":"48","author":"Wang","year":"2016","journal-title":"Pathology"},{"key":"10.1016\/j.apsb.2021.08.017_bib19","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1080\/14787210.2021.1851194","article-title":"Recent advances in the understanding of enterovirus A71 infection: a focus on neuropathogenesis","volume":"19","author":"Tee","year":"2021","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.apsb.2021.08.017_bib20","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/infdis\/129.3.304","article-title":"An apparently new enterovirus isolated from patients with disease of the central nervous system","volume":"129","author":"Schmidt","year":"1974","journal-title":"J Infect Dis"},{"key":"10.1016\/j.apsb.2021.08.017_bib21","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12929-019-0560-7","article-title":"Antivirals and vaccines for enterovirus A71","volume":"26","author":"Lin","year":"2019","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.apsb.2021.08.017_bib22","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1303224","article-title":"An inactivated enterovirus 71 vaccine in healthy children","volume":"370","author":"Li","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2021.08.017_bib23","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/infdis\/jiw502","article-title":"2-Year efficacy, immunogenicity, and safety of Vigoo enterovirus 71 vaccine in healthy Chinese children: a randomized open-label study","volume":"215","author":"Wei","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.apsb.2021.08.017_bib24","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa1304923","article-title":"Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China","volume":"370","author":"Zhu","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2021.08.017_bib25","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1080\/14760584.2018.1510326","article-title":"Recent development of enterovirus A vaccine candidates for the prevention of hand, foot, and mouth disease","volume":"17","author":"Fang","year":"2018","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.apsb.2021.08.017_bib26","article-title":"EV-A71 vaccine licensure: a first step for multivalent enterovirus vaccine to control HFMD and other severe diseases","volume":"5","author":"Mao","year":"2016","journal-title":"Emerg Microb Infect"},{"key":"10.1016\/j.apsb.2021.08.017_bib27","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jinf.2020.12.020","article-title":"Emergence of a non vaccine-cognate enterovirus A71 genotype C1 in mainland China","volume":"82","author":"Zeng","year":"2021","journal-title":"J Infect"},{"key":"10.1016\/j.apsb.2021.08.017_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008857","article-title":"Emergence of genotype C1 Enterovirus A71 and its link with antigenic variation of virus in Taiwan","volume":"16","author":"Huang","year":"2020","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.apsb.2021.08.017_bib29","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41598-019-56703-5","article-title":"Newly emerged enterovirus-A71 C4 sublineage may be more virulent than B5 in the 2015\u22122016 hand-foot-and-mouth disease outbreak in northern Vietnam","volume":"10","author":"Chu","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2021.08.017_bib30","doi-asserted-by":"crossref","first-page":"610568","DOI":"10.3389\/fmicb.2020.610568","article-title":"Novel naturally occurring mutations of enterovirus 71 associated with disease severity","volume":"11","author":"Chang","year":"2020","journal-title":"Front Microbiol"},{"key":"10.1016\/j.apsb.2021.08.017_bib31","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/s41579-018-0005-4","article-title":"The life cycle of non-polio enteroviruses and how to target it","volume":"16","author":"Baggen","year":"2018","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.apsb.2021.08.017_bib32","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12929-020-0615-9","article-title":"Cellular receptors for enterovirus A71","volume":"27","author":"Kobayashi","year":"2020","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.apsb.2021.08.017_bib33","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nm.1992","article-title":"Scavenger receptor B2 is a cellular receptor for enterovirus 71","volume":"15","author":"Yamayoshi","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2021.08.017_bib34","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/nm.1961","article-title":"Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71","volume":"15","author":"Nishimura","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2021.08.017_bib35","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/1743-422X-6-141","article-title":"Sialylated glycans as receptor and inhibitor of enterovirus 71 infection to DLD-1 intestinal cells","volume":"6","author":"Yang","year":"2009","journal-title":"Virol J"},{"key":"10.1016\/j.apsb.2021.08.017_bib36","doi-asserted-by":"crossref","first-page":"11809","DOI":"10.1128\/JVI.00297-11","article-title":"Annexin II binds to capsid protein VP1 of enterovirus 71 and enhances viral infectivity","volume":"85","author":"Yang","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.apsb.2021.08.017_bib37","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1128\/JVI.02226-12","article-title":"Enterovirus 71 uses cell surface heparan sulfate glycosaminoglycan as an attachment receptor","volume":"87","author":"Tan","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.apsb.2021.08.017_bib38","doi-asserted-by":"crossref","first-page":"5163","DOI":"10.1172\/JCI99411","article-title":"Human tryptophanyl-tRNA synthetase is an IFN-gamma-inducible entry factor for Enterovirus","volume":"128","author":"Yeung","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/j.apsb.2021.08.017_bib39","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nsmb.2255","article-title":"A sensor-adaptor mechanism for enterovirus uncoating from structures of EV71","volume":"19","author":"Wang","year":"2012","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.apsb.2021.08.017_bib40","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1128\/JVI.03029-13","article-title":"Human enterovirus 71 uncoating captured at atomic resolution","volume":"88","author":"Lyu","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.apsb.2021.08.017_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/e92d19e0-996a-4bfa-afdd-20dce770ed75","article-title":"The enterovirus 71 A-particle forms a gateway to allow genome release: a cryoEM study of picornavirus uncoating","volume":"9","author":"Shingler","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.apsb.2021.08.017_bib42","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3389\/fmicb.2018.00286","article-title":"Enterovirus A71 proteins: structure and function","volume":"9","author":"Yuan","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.apsb.2021.08.017_bib43","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00951-19","article-title":"Origins of enterovirus replication organelles established by whole-cell electron microscopy","volume":"10","author":"Melia","year":"2019","journal-title":"mBio"},{"key":"10.1016\/j.apsb.2021.08.017_bib44","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1128\/MMBR.00012-14","article-title":"Picornavirus morphogenesis","volume":"78","author":"Jiang","year":"2014","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1016\/j.apsb.2021.08.017_bib45","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/pro.5560031005","article-title":"Role and mechanism of the maturation cleavage of VP0 in poliovirus assembly: structure of the empty capsid assembly intermediate at 2.9 A resolution","volume":"3","author":"Basavappa","year":"1994","journal-title":"Protein Sci"},{"key":"10.1016\/j.apsb.2021.08.017_bib46","doi-asserted-by":"crossref","first-page":"9743","DOI":"10.1128\/jvi.71.12.9743-9752.1997","article-title":"Dissecting the roles of VP0 cleavage and RNA packaging in picornavirus capsid stabilization: the structure of empty capsids of foot-and-mouth disease virus","volume":"71","author":"Curry","year":"1997","journal-title":"J Virol"},{"key":"10.1016\/j.apsb.2021.08.017_bib47","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.15585\/mmwr.mm6937a7","article-title":"Progress toward poliovirus containment implementation\u2014worldwide, 2019\u20132020","volume":"69","author":"Moffett","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.apsb.2021.08.017_bib48","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.coviro.2020.06.006","article-title":"Enterovirus infection and acute flaccid myelitis","volume":"40","author":"Uprety","year":"2020","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.apsb.2021.08.017_bib49","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.virol.2010.12.014","article-title":"Enterovirus infections of the central nervous system","volume":"411","author":"Rhoades","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.apsb.2021.08.017_bib50","doi-asserted-by":"crossref","first-page":"6051","DOI":"10.3390\/v7112920","article-title":"Neurotropic enterovirus infections in the central nervous system","volume":"7","author":"Huang","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.apsb.2021.08.017_bib51","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1074\/jbc.M115.690941","article-title":"Transferrin receptor 1 facilitates poliovirus permeation of mouse brain capillary endothelial cells","volume":"291","author":"Mizutani","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2021.08.017_bib52","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1146\/annurev-immunol-042718-041417","article-title":"Neuroinflammation during RNA viral infections","volume":"37","author":"Klein","year":"2019","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.apsb.2021.08.017_bib53","doi-asserted-by":"crossref","first-page":"8996","DOI":"10.1128\/JVI.00236-07","article-title":"Retrograde axonal transport: a major transmission route of enterovirus 71 in mice","volume":"81","author":"Chen","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.apsb.2021.08.017_bib54","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1097\/NEN.0000000000000122","article-title":"Enterovirus 71 can directly infect the brainstem via cranial nerves and infection can be ameliorated by passive immunization","volume":"73","author":"Tan","year":"2014","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.apsb.2021.08.017_bib55","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ejmech.2019.06.008","article-title":"Back to the future: advances in development of broad-spectrum capsid-binding inhibitors of enteroviruses","volume":"178","author":"Egorova","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.apsb.2021.08.017_bib56","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00705-011-1222-6","article-title":"In\u00a0vitro and in\u00a0vivo evaluation of ribavirin and pleconaril antiviral activity against enterovirus 71 infection","volume":"157","author":"Zhang","year":"2012","journal-title":"Arch Virol"},{"key":"10.1016\/j.apsb.2021.08.017_bib57","doi-asserted-by":"crossref","first-page":"6990","DOI":"10.1128\/AAC.03328-14","article-title":"The capsid binder vapendavir and the novel protease inhibitor SG85 inhibit enterovirus 71 replication","volume":"58","author":"Tijsma","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.apsb.2021.08.017_bib58","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1021\/acsinfecdis.9b00284","article-title":"A novel capsid binding inhibitor displays potent antiviral activity against enterovirus D68","volume":"5","author":"Ma","year":"2019","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.apsb.2021.08.017_bib59","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S1473-3099(02)00277-3","article-title":"FDA panel rejects common cold treatment","volume":"2","author":"Senior","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.apsb.2021.08.017_bib60","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1093\/jac\/dkw101","article-title":"In\u00a0vitro and in\u00a0vivo studies of a potent capsid-binding inhibitor of enterovirus 71","volume":"71","author":"Ho","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.apsb.2021.08.017_bib61","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1021\/acs.jmedchem.9b01414","article-title":"Design, synthesis, and evaluation of novel enterovirus 71 inhibitors as therapeutic drug leads for the treatment of human hand, foot, and mouth disease","volume":"63","author":"Zhang","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2021.08.017_bib62","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1021\/acsmedchemlett.7b00188","article-title":"Discovery of potent EV71 capsid inhibitors for treatment of HFMD","volume":"8","author":"Li","year":"2017","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.apsb.2021.08.017_bib63","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41421-018-0073-7","article-title":"Coxsackievirus A10 atomic structure facilitating the discovery of a broad-spectrum inhibitor against human enteroviruses","volume":"5","author":"Chen","year":"2019","journal-title":"Cell Discov"},{"key":"10.1016\/j.apsb.2021.08.017_bib64","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.antiviral.2016.04.003","article-title":"Susceptibilities of enterovirus D68, enterovirus 71, and rhinovirus 87 strains to various antiviral compounds","volume":"131","author":"Smee","year":"2016","journal-title":"Antivir Res"},{"key":"10.1016\/j.apsb.2021.08.017_bib65","doi-asserted-by":"crossref","first-page":"7782","DOI":"10.1128\/AAC.01375-15","article-title":"Antiviral activity of broad-spectrum and enterovirus-specific inhibitors against clinical isolates of enterovirus D68","volume":"59","author":"Sun","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.apsb.2021.08.017_bib66","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12985-015-0330-4","article-title":"In\u00a0vitro characterisation of a pleconaril\/pirodavir-like compound with potent activity against rhinoviruses","volume":"12","author":"Lacroix","year":"2015","journal-title":"Virol J"},{"key":"10.1016\/j.apsb.2021.08.017_bib67","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1021\/acs.jmedchem.9b01737","article-title":"Scaffold simplification strategy leads to a novel generation of dual human immunodeficiency virus and enterovirus-A71 entry inhibitors","volume":"63","author":"Martinez-Gualda","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2021.08.017_bib68","article-title":"The approved pediatric drug suramin identified as a clinical candidate for the treatment of EV71 infection-suramin inhibits EV71 infection in\u00a0vitro and in\u00a0vivo","volume":"3","author":"Ren","year":"2014","journal-title":"Emerg Microb Infect"},{"key":"10.1016\/j.apsb.2021.08.017_bib69","doi-asserted-by":"crossref","first-page":"e01168-19","DOI":"10.1128\/AAC.01168-19","article-title":"100 years of suramin","volume":"64","author":"Wiedemar","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.apsb.2021.08.017_bib70","doi-asserted-by":"crossref","first-page":"42902","DOI":"10.1038\/srep42902","article-title":"Suramin interacts with the positively charged region surrounding the 5-fold axis of the EV-A71 capsid and inhibits multiple enterovirus A","volume":"7","author":"Ren","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2021.08.017_bib71","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005184","article-title":"The suramin derivative NF449 interacts with the 5-fold vertex of the enterovirus A71 capsid to prevent virus attachment to PSGL-1 and heparan sulfate","volume":"11","author":"Nishimura","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.apsb.2021.08.017_bib72","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00061-19","article-title":"In\u00a0vitro and in\u00a0vivo inhibition of the infectivity of human enterovirus 71 by a sulfonated food azo dye, brilliant black BN","volume":"93","author":"Meng","year":"2019","journal-title":"J Virol"},{"key":"10.1016\/j.apsb.2021.08.017_bib73","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1021\/acsinfecdis.9b00179","article-title":"Fluoxetine inhibits enterovirus replication by targeting the viral 2C protein in a stereospecific manner","volume":"5","author":"Bauer","year":"2019","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.apsb.2021.08.017_bib74","doi-asserted-by":"crossref","first-page":"e2118","DOI":"10.1212\/WNL.0000000000006670","article-title":"Safety, tolerability, and efficacy of fluoxetine as an antiviral for acute flaccid myelitis","volume":"92","author":"Messacar","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.apsb.2021.08.017_bib75","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1001\/jamaneurol.2014.4625","article-title":"Rationale for the evaluation of fluoxetine in the treatment of enterovirus D68-associated acute flaccid myelitis","volume":"72","author":"Tyler","year":"2015","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.apsb.2021.08.017_bib76","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000904","article-title":"Rational design of highly potent broad-spectrum enterovirus inhibitors targeting the nonstructural protein 2C","volume":"18","author":"Bauer","year":"2020","journal-title":"PLoS Biol"},{"key":"10.1016\/j.apsb.2021.08.017_bib77","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1128\/AAC.02182-15","article-title":"Screening of a library of FDA-approved drugs identifies several enterovirus replication inhibitors that target viral protein 2C","volume":"60","author":"Ulferts","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.apsb.2021.08.017_bib78","doi-asserted-by":"crossref","first-page":"4074","DOI":"10.1021\/acs.jmedchem.9b00115","article-title":"Discovery of quinoline analogues as potent antivirals against enterovirus D68 (EV-D68)","volume":"62","author":"Musharrafieh","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2021.08.017_bib79","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1021\/acs.jmedchem.7b01863","article-title":"Synthesis and structure\u2013activity relationship (SAR) studies of novel pyrazolopyridine derivatives as inhibitors of enterovirus replication","volume":"61","author":"Xing","year":"2018","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2021.08.017_bib80","doi-asserted-by":"crossref","first-page":"8755","DOI":"10.1021\/acs.jmedchem.1c00758","article-title":"Discovery of potent and broad-spectrum pyrazolopyridine-containing antivirals against enteroviruses D68, A71, and coxsackievirus B3 by targeting the viral 2C protein","volume":"64","author":"Hu","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2021.08.017_bib81","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/S0140-6736(81)92520-4","article-title":"The activity of enviroxime against rhinovirus infection in man","volume":"1","author":"Phillpotts","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.apsb.2021.08.017_bib82","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1128\/AAC.27.1.102","article-title":"Controlled trial of enviroxime against natural rhinovirus infections in a community","volume":"27","author":"Miller","year":"1985","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.apsb.2021.08.017_bib83","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1128\/jvi.69.7.4189-4197.1995","article-title":"The antiviral compound enviroxime targets the 3A coding region of rhinovirus and poliovirus","volume":"69","author":"Heinz","year":"1995","journal-title":"J Virol"},{"key":"10.1016\/j.apsb.2021.08.017_bib84","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1128\/AAC.05108-14","article-title":"Discovery of itraconazole with broad-spectrum in\u00a0vitro antienterovirus activity that targets nonstructural protein 3A","volume":"59","author":"Gao","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.apsb.2021.08.017_bib85","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.celrep.2014.12.054","article-title":"Itraconazole inhibits enterovirus replication by targeting the oxysterol-binding protein","volume":"10","author":"Strating","year":"2015","journal-title":"Cell Rep"},{"key":"10.1016\/j.apsb.2021.08.017_bib86","doi-asserted-by":"crossref","first-page":"10319","DOI":"10.1128\/JVI.00787-11","article-title":"Enterovirus 71 and coxsackievirus A16 3C proteases: binding to rupintrivir and their substrates and anti-hand, foot, and mouth disease virus drug design","volume":"85","author":"Lu","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.apsb.2021.08.017_bib87","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02221-18","article-title":"Validating enterovirus D68-2Apro as an antiviral drug target and the discovery of telaprevir as a potent D68-2Apro inhibitor","volume":"93","author":"Musharrafieh","year":"2019","journal-title":"J Virol"},{"key":"10.1016\/j.apsb.2021.08.017_bib88","doi-asserted-by":"crossref","first-page":"11754","DOI":"10.1128\/JVI.01348-12","article-title":"Broad-spectrum antivirals against 3C or 3C-like proteases of picornaviruses, noroviruses, and coronaviruses","volume":"86","author":"Kim","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.apsb.2021.08.017_bib89","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1021\/acsinfecdis.0c00761","article-title":"Boceprevir, calpain inhibitors II and XII, and GC-376 have broad-spectrum antiviral activity against coronaviruses in cell culture","volume":"7","author":"Hu","year":"2021","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.apsb.2021.08.017_bib90","doi-asserted-by":"crossref","first-page":"8159","DOI":"10.1038\/s41598-020-65152-4","article-title":"Drug repurposing of pyrimidine analogs as potent antiviral compounds against human enterovirus A71 infection with potential clinical applications","volume":"10","author":"Sun","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2021.08.017_bib91","doi-asserted-by":"crossref","first-page":"e00204","DOI":"10.1128\/JVI.00204-20","article-title":"The pyrimidine analog FNC potently inhibits the replication of multiple enteroviruses","volume":"94","author":"Xu","year":"2020","journal-title":"J Virol"},{"key":"10.1016\/j.apsb.2021.08.017_bib92","doi-asserted-by":"crossref","first-page":"5357","DOI":"10.1128\/AAC.01073-16","article-title":"In\u00a0vitro assessment of combinations of enterovirus inhibitors against enterovirus 71","volume":"60","author":"Wang","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.apsb.2021.08.017_bib93","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.antiviral.2014.10.009","article-title":"An adenosine nucleoside analogue NITD008 inhibits EV71 proliferation","volume":"112","author":"Shang","year":"2014","journal-title":"Antivir Res"},{"key":"10.1016\/j.apsb.2021.08.017_bib94","doi-asserted-by":"crossref","first-page":"4775","DOI":"10.1038\/s41467-020-18594-3","article-title":"IRES-targeting small molecule inhibits enterovirus 71 replication via allosteric stabilization of a ternary complex","volume":"11","author":"Davila-Calderon","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2021.08.017_bib95","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aar5759","article-title":"Prunin suppresses viral IRES activity and is a potential candidate for treating enterovirus A71 infection","volume":"11","author":"Gunaseelan","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.apsb.2021.08.017_bib96","doi-asserted-by":"crossref","first-page":"104650","DOI":"10.1016\/j.antiviral.2019.104650","article-title":"Emetine protects mice from enterovirus infection by inhibiting viral translation","volume":"173","author":"Tang","year":"2020","journal-title":"Antivir Res"},{"key":"10.1016\/j.apsb.2021.08.017_bib97","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.antiviral.2015.02.013","article-title":"Broad-range inhibition of enterovirus replication by OSW-1, a natural compound targeting OSBP","volume":"117","author":"Albulescu","year":"2015","journal-title":"Antivir Res"},{"key":"10.1016\/j.apsb.2021.08.017_bib98","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1021\/acsinfecdis.7b00053","article-title":"Allosteric regulation of phosphatidylinositol 4-kinase III beta by an antipicornavirus compound MDL-860","volume":"3","author":"Arita","year":"2017","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.apsb.2021.08.017_bib99","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1128\/AAC.22.4.635","article-title":"Antiviral activity and mechanism of action of 2-(3,4-dichlorophenoxy)-5-nitrobenzonitrile (MDL-860)","volume":"22","author":"Torney","year":"1982","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.apsb.2021.08.017_bib100","doi-asserted-by":"crossref","first-page":"4056","DOI":"10.1021\/acs.jmedchem.9b00091","article-title":"Discovery, optimization, and target identification of novel potent broad-spectrum antiviral inhibitors","volume":"62","author":"Yang","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2021.08.017_bib101","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.1073\/pnas.1222379110","article-title":"Structure of human enterovirus 71 in complex with a capsid-binding inhibitor","volume":"110","author":"Plevka","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2021.08.017_bib102","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12929-021-00708-8","article-title":"Antivirals blocking entry of enteroviruses and therapeutic potential","volume":"28","author":"Anasir","year":"2021","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.apsb.2021.08.017_bib103","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nsmb.2769","article-title":"More-powerful virus inhibitors from structure-based analysis of HEV71 capsid-binding molecules","volume":"21","author":"De Colibus","year":"2014","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.apsb.2021.08.017_bib104","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1021\/acs.jmedchem.5b01803","article-title":"Identification and structure\u2013activity relationships of diarylhydrazides as novel potent and selective human enterovirus inhibitors","volume":"59","author":"Han","year":"2016","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2021.08.017_bib105","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1021\/acsinfecdis.0c00404","article-title":"Characterization of a new antienterovirus D68 compound purified from avocado","volume":"6","author":"Arita","year":"2020","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.apsb.2021.08.017_bib106","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.antiviral.2017.04.006","article-title":"Characterization of three small molecule inhibitors of enterovirus 71 identified from screening of a library of natural products","volume":"143","author":"Li","year":"2017","journal-title":"Antivir Res"},{"key":"10.1016\/j.apsb.2021.08.017_bib107","doi-asserted-by":"crossref","first-page":"5472","DOI":"10.1021\/acs.jmedchem.7b00175","article-title":"A novel series of highly potent small molecule inhibitors of rhinovirus replication","volume":"60","author":"Kim","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2021.08.017_bib108","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007760","article-title":"Viral engagement with host receptors blocked by a novel class of tryptophan dendrimers that targets the 5-fold-axis of the enterovirus-A71 capsid","volume":"15","author":"Sun","year":"2019","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.apsb.2021.08.017_bib109","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1080\/22221751.2020.1767512","article-title":"Rosmarinic acid exhibits broad anti-enterovirus A71 activity by inhibiting the interaction between the five-fold axis of capsid VP1 and cognate sulfated receptors","volume":"9","author":"Hsieh","year":"2020","journal-title":"Emerg Microb Infect"},{"key":"10.1016\/j.apsb.2021.08.017_bib110","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1099\/0022-1317-83-6-1367","article-title":"Infection with enterovirus 71 or expression of its 2A protease induces apoptotic cell death","volume":"83","author":"Kuo","year":"2002","journal-title":"J Gen Virol"},{"key":"10.1016\/j.apsb.2021.08.017_bib111","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1093\/jac\/dks304","article-title":"Blocking human enterovirus 71 replication by targeting viral 2A protease","volume":"67","author":"Falah","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.apsb.2021.08.017_bib112","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.3390\/v7062764","article-title":"Antiviral potential of a novel compound CW-33 against enterovirus A71 via inhibition of viral 2A protease","volume":"7","author":"Wang","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.apsb.2021.08.017_bib113","doi-asserted-by":"crossref","first-page":"7348","DOI":"10.1128\/JVI.03541-12","article-title":"Conformational plasticity of the 2A proteinase from enterovirus 71","volume":"87","author":"Cai","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.apsb.2021.08.017_bib114","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1128\/AAC.02274-15","article-title":"A conserved inhibitory mechanism of a lycorine derivative against enterovirus and hepatitis C virus","volume":"60","author":"Guo","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.apsb.2021.08.017_bib115","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/cr.2011.112","article-title":"DIDS blocks a chloride-dependent current that is mediated by the 2B protein of enterovirus 71","volume":"21","author":"Xie","year":"2011","journal-title":"Cell Res"},{"key":"10.1016\/j.apsb.2021.08.017_bib116","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrmicro2820","article-title":"Viroporins: structure and biological functions","volume":"10","author":"Nieva","year":"2012","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.apsb.2021.08.017_bib117","doi-asserted-by":"crossref","first-page":"9862","DOI":"10.1128\/JVI.01499-16","article-title":"Enterovirus 71 2B induces cell apoptosis by directly inducing the conformational activation of the proapoptotic protein Bax","volume":"90","author":"Cong","year":"2016","journal-title":"J Virol"},{"key":"10.1016\/j.apsb.2021.08.017_bib118","doi-asserted-by":"crossref","first-page":"615965","DOI":"10.3389\/fmicb.2020.615965","article-title":"The structure, function, and mechanisms of action of enterovirus non-structural protein 2C","volume":"11","author":"Wang","year":"2020","journal-title":"Front Microbiol"},{"key":"10.1016\/j.apsb.2021.08.017_bib119","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005067","article-title":"Human enterovirus nonstructural protein 2CATPase functions as both an RNA helicase and ATP-independent RNA chaperone","volume":"11","author":"Xia","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.apsb.2021.08.017_bib120","doi-asserted-by":"crossref","first-page":"104781","DOI":"10.1016\/j.antiviral.2020.104781","article-title":"Synthesis and antiviral effect of novel fluoxetine analogues as enterovirus 2C inhibitors","volume":"178","author":"Manganaro","year":"2020","journal-title":"Antivir Res"},{"key":"10.1016\/j.apsb.2021.08.017_bib121","doi-asserted-by":"crossref","first-page":"103981","DOI":"10.1016\/j.bioorg.2020.103981","article-title":"Development of broad-spectrum enterovirus antivirals based on quinoline scaffold","volume":"101","author":"Musharrafieh","year":"2020","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.apsb.2021.08.017_bib122","doi-asserted-by":"crossref","first-page":"112310","DOI":"10.1016\/j.ejmech.2020.112310","article-title":"Identification of dibucaine derivatives as novel potent enterovirus 2C helicase inhibitors: in\u00a0vitro, in\u00a0vivo, and combination therapy study","volume":"202","author":"Tang","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.apsb.2021.08.017_bib123","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1021\/acsinfecdis.0c00383","article-title":"Pharmacological characterization of the mechanism of action of R523062, a promising antiviral for enterovirus D68","volume":"6","author":"Ma","year":"2020","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.apsb.2021.08.017_bib124","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1128\/AAC.02646-15","article-title":"Discovery of structurally diverse small-molecule compounds with broad antiviral activity against enteroviruses","volume":"60","author":"Zuo","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.apsb.2021.08.017_bib125","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.1128\/JVI.01338-07","article-title":"The thiazolobenzimidazole TBZE-029 inhibits enterovirus replication by targeting a short region immediately downstream from motif C in the nonstructural protein 2C","volume":"82","author":"De Palma","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.apsb.2021.08.017_bib126","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1128\/AAC.02084-12","article-title":"Selective serotonin reuptake inhibitor fluoxetine inhibits replication of human enteroviruses B and D by targeting viral protein 2C","volume":"57","author":"Ulferts","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.apsb.2021.08.017_bib127","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1099\/vir.0.2008\/002915-0","article-title":"Characterization of pharmacologically active compounds that inhibit poliovirus and enterovirus 71 infectivity","volume":"89","author":"Arita","year":"2008","journal-title":"J Gen Virol"},{"key":"10.1016\/j.apsb.2021.08.017_bib128","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007304","article-title":"Crystal structure of a soluble fragment of poliovirus 2CATPase","volume":"14","author":"Guan","year":"2018","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.apsb.2021.08.017_bib129","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1602573","article-title":"Crystal structure of 2C helicase from enterovirus 71","volume":"3","author":"Guan","year":"2017","journal-title":"Sci Adv"},{"key":"10.1016\/j.apsb.2021.08.017_bib130","article-title":"Fluoxetine targets an allosteric site in the enterovirus 2C AAA+ ATPase and stabilizes the hexameric complex","author":"Hurdiss","year":"2021","journal-title":"bioRxiv"},{"key":"10.1016\/j.apsb.2021.08.017_bib131","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.3389\/fmicb.2020.01817","article-title":"Enterovirus replication organelles and inhibitors of their formation","volume":"11","author":"Li","year":"2020","journal-title":"Front Microbiol"},{"key":"10.1016\/j.apsb.2021.08.017_bib132","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005912","article-title":"Building viral replication organelles: close encounters of the membrane types","volume":"12","author":"Nagy","year":"2016","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.apsb.2021.08.017_bib133","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00791-17","article-title":"Enterovirus 3A facilitates viral replication by promoting phosphatidylinositol 4-kinase IIIbeta-ACBD3 interaction","volume":"91","author":"Xiao","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.apsb.2021.08.017_bib134","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02742-18","article-title":"ACBD3 is an essential pan-enterovirus host factor that mediates the interaction between viral 3A protein and cellular protein PI4KB","volume":"10","author":"Lyoo","year":"2019","journal-title":"mBio"},{"key":"10.1016\/j.apsb.2021.08.017_bib135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007962","article-title":"Convergent evolution in the mechanisms of ACBD3 recruitment to picornavirus replication sites","volume":"15","author":"Horova","year":"2019","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.apsb.2021.08.017_bib136","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1099\/vir.0.023374-0","article-title":"A bifunctional anti-enterovirus compound that inhibits replication and the early stage of enterovirus 71 infection","volume":"91","author":"Arita","year":"2010","journal-title":"J Gen Virol"},{"key":"10.1016\/j.apsb.2021.08.017_bib137","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1099\/vir.0.012096-0","article-title":"Cellular kinase inhibitors that suppress enterovirus replication have a conserved target in viral protein 3A similar to that of enviroxime","volume":"90","author":"Arita","year":"2009","journal-title":"J Gen Virol"},{"key":"10.1016\/j.apsb.2021.08.017_bib138","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1128\/AAC.00934-08","article-title":"Mutations in the nonstructural protein 3A confer resistance to the novel enterovirus replication inhibitor TTP-8307","volume":"53","author":"De Palma","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.apsb.2021.08.017_bib139","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.antiviral.2017.01.008","article-title":"Uncovering oxysterol-binding protein (OSBP) as a target of the anti-enteroviral compound TTP-8307","volume":"140","author":"Albulescu","year":"2017","journal-title":"Antivir Res"},{"key":"10.1016\/j.apsb.2021.08.017_bib140","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02372-19","article-title":"Antifungal triazole posaconazole targets an early stage of the parechovirus A3 life cycle","volume":"64","author":"Rhoden","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.apsb.2021.08.017_bib141","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-5793(01)02885-X","article-title":"Cleavage of translation initiation factor 4AI (eIF4AI) but not eIF4AII by foot-and-mouth disease virus 3C protease: identification of the eIF4AI cleavage site","volume":"507","author":"Li","year":"2001","journal-title":"FEBS Lett"},{"key":"10.1016\/j.apsb.2021.08.017_bib142","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.virol.2008.05.019","article-title":"Cleavage of eukaryotic initiation factor eIF5B by enterovirus 3C proteases","volume":"378","author":"de Breyne","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.apsb.2021.08.017_bib143","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3390\/v8030082","article-title":"Roles of the picornaviral 3C proteinase in the viral life cycle and host cells","volume":"8","author":"Sun","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.apsb.2021.08.017_bib144","doi-asserted-by":"crossref","first-page":"9414","DOI":"10.1021\/acs.jmedchem.5b01013","article-title":"Cyanohydrin as an anchoring group for potent and selective inhibitors of enterovirus 71 3C protease","volume":"58","author":"Zhai","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2021.08.017_bib145","doi-asserted-by":"crossref","first-page":"10333","DOI":"10.1021\/acs.jmedchem.8b01335","article-title":"4-Iminooxazolidin-2-one as a bioisostere of the cyanohydrin moiety: inhibitors of enterovirus 71 3C protease","volume":"61","author":"Ma","year":"2018","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2021.08.017_bib146","doi-asserted-by":"crossref","first-page":"6146","DOI":"10.1021\/acs.jmedchem.9b00387","article-title":"Application of dually activated michael acceptor to the rational design of reversible covalent inhibitor for enterovirus 71 3C protease","volume":"62","author":"Ma","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2021.08.017_bib147","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.ejmech.2016.10.019","article-title":"Identification and biochemical characterization of DC07090 as a novel potent small molecule inhibitor against human enterovirus 71 3C protease by structure-based virtual screening","volume":"124","author":"Ma","year":"2016","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.apsb.2021.08.017_bib148","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.1128\/AAC.47.12.3907-3916.2003","article-title":"Phase II, randomized, double-blind, placebo-controlled studies of ruprintrivir nasal spray 2-percent suspension for prevention and treatment of experimentally induced rhinovirus colds in healthy volunteers","volume":"47","author":"Hayden","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.apsb.2021.08.017_bib149","doi-asserted-by":"crossref","first-page":"10021","DOI":"10.1128\/JVI.05107-11","article-title":"Crystal structures of enterovirus 71 3C protease complexed with rupintrivir reveal the roles of catalytically important residues","volume":"85","author":"Wang","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.apsb.2021.08.017_bib150","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1021\/acs.jmedchem.7b01440","article-title":"Phenylthiomethyl ketone-based fragments show selective and irreversible inhibition of enteroviral 3C proteases","volume":"61","author":"Schulz","year":"2018","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2021.08.017_bib151","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1128\/AAC.00049-15","article-title":"Peptidyl aldehyde NK-1.8k suppresses enterovirus 71 and enterovirus 68 infection by targeting protease 3C","volume":"59","author":"Wang","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.apsb.2021.08.017_bib152","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1021\/acsinfecdis.0c00761","article-title":"Boceprevir, calpain inhibitors II and XII, and GC-376 have broad-spectrum antiviral activity against coronaviruses","volume":"7","author":"Hu","year":"2021","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.apsb.2021.08.017_bib153","article-title":"Discovery of a novel inhibitor of coronavirus 3CL protease as a clinical candidate for the potential treatment of COVID-19","author":"Boras","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.apsb.2021.08.017_bib154","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00298-17","article-title":"Structure of the enterovirus 71 3C protease in complex with NK-1.8k and indications for the development of antienterovirus protease inhibitor","volume":"61","author":"Wang","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.apsb.2021.08.017_bib155","doi-asserted-by":"crossref","first-page":"4562","DOI":"10.1021\/acs.jmedchem.9b01828","article-title":"alpha-Ketoamides as broad-spectrum inhibitors of coronavirus and enterovirus replication: structure-based design, synthesis, and activity assessment","volume":"63","author":"Zhang","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2021.08.017_bib156","doi-asserted-by":"crossref","first-page":"115551","DOI":"10.1016\/j.bmc.2020.115551","article-title":"Design, synthesis, and evaluation of a novel macrocyclic anti-EV71 agent","volume":"28","author":"Li","year":"2020","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.apsb.2021.08.017_bib157","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01092-19","article-title":"Activity-based protein profiling identifies ATG4B as a key host factor for enterovirus 71 proliferation","volume":"93","author":"Sun","year":"2019","journal-title":"J Virol"},{"key":"10.1016\/j.apsb.2021.08.017_bib158","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1128\/JVI.01123-12","article-title":"3C protease of enterovirus 68: structure-based design of Michael acceptor inhibitors and their broad-spectrum antiviral effects against picornaviruses","volume":"87","author":"Tan","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.apsb.2021.08.017_bib159","doi-asserted-by":"crossref","first-page":"33663","DOI":"10.1038\/srep33663","article-title":"Antiviral activities of peptide-based covalent inhibitors of the Enterovirus 71 3C protease","volume":"6","author":"Tan","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2021.08.017_bib160","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1016\/j.bmcl.2016.05.036","article-title":"Design, synthesis, and biological evaluation of anti-EV71 agents","volume":"26","author":"Li","year":"2016","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.apsb.2021.08.017_bib161","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1016\/j.bmcl.2016.02.039","article-title":"Synthesis and\u00a0structure\u2013activity relationship of alpha-keto amides as enterovirus 71 3C protease inhibitors","volume":"26","author":"Zeng","year":"2016","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.apsb.2021.08.017_bib162","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ejmech.2016.08.064","article-title":"Structure\u2013activity relationship study of peptidomimetic aldehydes as enterovirus 71 3C protease inhibitors","volume":"124","author":"Zhai","year":"2016","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.apsb.2021.08.017_bib163","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1021\/acsinfecdis.0c00815","article-title":"Challenges for targeting SARS-CoV-2 proteases as a therapeutic strategy for COVID-19","volume":"7","author":"Steuten","year":"2021","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.apsb.2021.08.017_bib164","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1021\/acs.jmedchem.1c00509","article-title":"An expedited approach towards the rationale design of non-covalent SARS-CoV-2 main protease inhibitors with in\u00a0vitro antiviral activity","volume":"65","author":"Kitamura","year":"2022","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2021.08.017_bib165","doi-asserted-by":"crossref","first-page":"20435","DOI":"10.1073\/pnas.0907010106","article-title":"An adenosine nucleoside inhibitor of dengue virus","volume":"106","author":"Yin","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2021.08.017_bib166","doi-asserted-by":"crossref","first-page":"11915","DOI":"10.1128\/JVI.01207-14","article-title":"Inhibition of enterovirus 71 by adenosine analog NITD008","volume":"88","author":"Deng","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.apsb.2021.08.017_bib167","doi-asserted-by":"crossref","first-page":"127599","DOI":"10.1016\/j.bmcl.2020.127599","article-title":"Structure activity relationship of novel antiviral nucleosides against Enterovirus A71","volume":"30","author":"Tosh","year":"2020","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.apsb.2021.08.017_bib168","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1126\/science.abc1560","article-title":"Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir","volume":"368","author":"Yin","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.apsb.2021.08.017_bib169","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1128\/AAC.00101-09","article-title":"Novel antiviral agent DTriP-22 targets RNA-dependent RNA polymerase of enterovirus 71","volume":"53","author":"Chen","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.apsb.2021.08.017_bib170","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/jac\/dkp502","article-title":"Inhibition of enterovirus 71 replication and the viral 3D polymerase by aurintricarboxylic acid","volume":"65","author":"Hung","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.apsb.2021.08.017_bib171","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004733","article-title":"The RNA template channel of the RNA-dependent RNA polymerase as a target for development of antiviral therapy of multiple genera within a virus family","volume":"11","author":"van der Linden","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.apsb.2021.08.017_bib172","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.antiviral.2014.10.003","article-title":"BPR-3P0128 inhibits RNA-dependent RNA polymerase elongation and VPg uridylylation activities of Enterovirus 71","volume":"112","author":"Velu","year":"2014","journal-title":"Antivir Res"},{"key":"10.1016\/j.apsb.2021.08.017_bib173","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.antiviral.2018.11.016","article-title":"The evolution of antiviral nucleoside analogues: a review for chemists and non-chemists. Part II: complex modifications to the nucleoside scaffold","volume":"162","author":"Yates","year":"2019","journal-title":"Antivir Res"},{"key":"10.1016\/j.apsb.2021.08.017_bib174","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.antiviral.2018.04.004","article-title":"The evolution of nucleoside analogue antivirals: a review for chemists and non-chemists. Part 1: early structural modifications to the nucleoside scaffold","volume":"154","author":"Seley-Radtke","year":"2018","journal-title":"Antivir Res"},{"key":"10.1016\/j.apsb.2021.08.017_bib175","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12929-019-0607-9","article-title":"Translation control of Enterovirus A71 gene expression","volume":"27","author":"Lai","year":"2020","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.apsb.2021.08.017_bib176","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3390\/v11070625","article-title":"Antiviral efficacy of flavonoids against enterovirus 71 infection in\u00a0vitro and in newborn mice","volume":"11","author":"Dai","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.apsb.2021.08.017_bib177","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1099\/jgv.0.000431","article-title":"Idarubicin is a broad-spectrum enterovirus replication inhibitor that selectively targets the virus internal ribosomal entry site","volume":"97","author":"Hou","year":"2016","journal-title":"J Gen Virol"},{"key":"10.1016\/j.apsb.2021.08.017_bib178","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1126\/science.1241475","article-title":"Structure of the CCR5 chemokine receptor-HIV entry inhibitor maraviroc complex","volume":"341","author":"Tan","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.apsb.2021.08.017_bib179","doi-asserted-by":"crossref","first-page":"9658","DOI":"10.1128\/JVI.05063-11","article-title":"Host factors in enterovirus 71 replication","volume":"85","author":"Shih","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.apsb.2021.08.017_bib180","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/17460441.2019.1659241","article-title":"Recent progress and challenges in drug development to fight hand, foot and mouth disease","volume":"15","author":"Lim","year":"2020","journal-title":"Expet Opin Drug Discov"},{"key":"10.1016\/j.apsb.2021.08.017_bib181","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/1348-0421.12144","article-title":"Phosphatidylinositol-4 kinase III beta and oxysterol-binding protein accumulate unesterified cholesterol on poliovirus-induced membrane structure","volume":"58","author":"Arita","year":"2014","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.apsb.2021.08.017_bib182","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.chom.2014.10.003","article-title":"Rhinovirus uses a phosphatidylinositol 4-phosphate\/cholesterol counter-current for the formation of replication compartments at the ER\u2013Golgi interface","volume":"16","author":"Roulin","year":"2014","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.apsb.2021.08.017_bib183","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nchembio.625","article-title":"Natural products reveal cancer cell dependence on oxysterol-binding proteins","volume":"7","author":"Burgett","year":"2011","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.apsb.2021.08.017_bib184","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1021\/acschembio.8b00984","article-title":"Transient compound treatment induces a multigenerational reduction of oxysterol-binding protein (OSBP) levels and prophylactic antiviral activity","volume":"14","author":"Roberts","year":"2019","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.apsb.2021.08.017_bib185","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1083\/jcb.201107058","article-title":"Inhibition of pyrimidine synthesis reverses viral virulence factor-mediated block of mRNA nuclear export","volume":"196","author":"Zhang","year":"2012","journal-title":"J Cell Biol"},{"key":"10.1016\/j.apsb.2021.08.017_bib186","doi-asserted-by":"crossref","first-page":"5777","DOI":"10.1073\/pnas.1101143108","article-title":"Broad-spectrum antiviral that interferes with de novo pyrimidine biosynthesis","volume":"108","author":"Hoffmann","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2021.08.017_bib187","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1099\/jgv.0.000758","article-title":"Broad-spectrum inhibition of common respiratory RNA viruses by a pyrimidine synthesis inhibitor with involvement of the host antiviral response","volume":"98","author":"Cheung","year":"2017","journal-title":"J Gen Virol"},{"key":"10.1016\/j.apsb.2021.08.017_bib188","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1021\/acsinfecdis.9b00070","article-title":"Efficient blocking of enterovirus 71 infection by heparan sulfate analogues acting as decoy receptors","volume":"5","author":"Earley","year":"2019","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.apsb.2021.08.017_bib189","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.virusres.2012.06.025","article-title":"In\u00a0vitro evaluation of the antiviral activity of heparan sulfate mimetic compounds against Enterovirus 71","volume":"169","author":"Pourianfar","year":"2012","journal-title":"Virus Res"},{"key":"10.1016\/j.apsb.2021.08.017_bib190","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.antiviral.2016.08.009","article-title":"Inhibition of enterovirus VP4 myristoylation is a potential antiviral strategy for hand, foot and mouth disease","volume":"133","author":"Tan","year":"2016","journal-title":"Antivir Res"},{"key":"10.1016\/j.apsb.2021.08.017_bib191","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.antiviral.2005.03.005","article-title":"Lactoferrin inhibits enterovirus 71 infection by binding to VP1 protein and host cells","volume":"67","author":"Weng","year":"2005","journal-title":"Antivir Res"},{"key":"10.1016\/j.apsb.2021.08.017_bib192","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba7910","article-title":"Viruses harness YxxO motif to interact with host AP2M1 for replication: a vulnerable broad-spectrum antiviral target","volume":"6","author":"Yuan","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.apsb.2021.08.017_bib193","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ejmech.2019.04.048","article-title":"Design, synthesis and pharmacological evaluation of a novel mTOR-targeted anti-EV71 agent","volume":"175","author":"Hao","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.apsb.2021.08.017_bib194","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.antiviral.2018.02.002","article-title":"GS-9620 inhibits enterovirus 71 replication mainly through the NF-kappaB and PI3K\u2013AKT signaling pathways","volume":"153","author":"Zhang","year":"2018","journal-title":"Antivir Res"},{"key":"10.1016\/j.apsb.2021.08.017_bib195","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.3390\/v5071684","article-title":"Cyclophilins as modulators of viral replication","volume":"5","author":"Frausto","year":"2013","journal-title":"Viruses"},{"key":"10.1016\/j.apsb.2021.08.017_bib196","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.1016\/j.bmcl.2013.05.101","article-title":"Cyclophilin inhibitors as antiviral agents","volume":"23","author":"Peel","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.apsb.2021.08.017_bib197","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.bbrc.2012.07.024","article-title":"Cyclophilin A and viral infections","volume":"424","author":"Zhou","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.apsb.2021.08.017_bib198","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000524","article-title":"Target cell cyclophilins facilitate human papillomavirus type 16 infection","volume":"5","author":"Bienkowska-Haba","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.apsb.2021.08.017_bib199","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.antiviral.2016.07.019","article-title":"Discovery of cyclosporine A and its analogs as broad-spectrum anti-influenza drugs with a high in\u00a0vitro genetic barrier of drug resistance","volume":"133","author":"Ma","year":"2016","journal-title":"Antivir Res"},{"key":"10.1016\/j.apsb.2021.08.017_bib200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004422","article-title":"Cyclophilin A associates with enterovirus-71 virus capsid and plays an essential role in viral infection as an uncoating regulator","volume":"10","author":"Qing","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.apsb.2021.08.017_bib201","doi-asserted-by":"crossref","first-page":"5682","DOI":"10.1016\/j.bmcl.2015.11.002","article-title":"Identification, synthesis and pharmacological evaluation of novel anti-EV71 agents via cyclophilin A inhibition","volume":"25","author":"Yan","year":"2015","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.apsb.2021.08.017_bib202","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ijantimicag.2018.12.009","article-title":"Spiramycin and azithromycin, safe for administration to children, exert antiviral activity against enterovirus A71 in\u00a0vitro and in\u00a0vivo","volume":"53","author":"Zeng","year":"2019","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.apsb.2021.08.017_bib203","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.antiviral.2017.11.017","article-title":"An evaluation of chloroquine as a broad-acting antiviral against hand, foot and mouth disease","volume":"149","author":"Tan","year":"2018","journal-title":"Antivir Res"},{"key":"10.1016\/j.apsb.2021.08.017_bib204","doi-asserted-by":"crossref","first-page":"9618","DOI":"10.3390\/ijms14059618","article-title":"Chebulagic acid, a hydrolyzable tannin, exhibited antiviral activity in\u00a0vitro and in\u00a0vivo against human enterovirus 71","volume":"14","author":"Yang","year":"2013","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2021.08.017_bib205","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1021\/acsinfecdis.0c00096","article-title":"Sodium copper chlorophyllin is highly effective against enterovirus (EV) A71 infection by blocking its entry into the host cell","volume":"6","author":"Liu","year":"2020","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.apsb.2021.08.017_bib206","doi-asserted-by":"crossref","first-page":"104607","DOI":"10.1016\/j.antiviral.2019.104607","article-title":"Antiviral effects of simeprevir on multiple viruses","volume":"172","author":"Li","year":"2019","journal-title":"Antivir Res"},{"key":"10.1016\/j.apsb.2021.08.017_bib207","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1016\/j.bmcl.2012.01.102","article-title":"Antiviral effect of geraniin on human enterovirus 71 in\u00a0vitro and in\u00a0vivo","volume":"22","author":"Yang","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.apsb.2021.08.017_bib208","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.phymed.2012.08.012","article-title":"Antiviral activity of punicalagin toward human enterovirus 71 in\u00a0vitro and in\u00a0vivo","volume":"20","author":"Yang","year":"2012","journal-title":"Phytomedicine"},{"key":"10.1016\/j.apsb.2021.08.017_bib209","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1186\/1743-422X-8-483","article-title":"Lycorine reduces mortality of human enterovirus 71-infected mice by inhibiting virus replication","volume":"8","author":"Liu","year":"2011","journal-title":"Virol J"},{"key":"10.1016\/j.apsb.2021.08.017_bib210","doi-asserted-by":"crossref","first-page":"10370","DOI":"10.3390\/molecules170910370","article-title":"Antiviral effect of matrine against human enterovirus 71","volume":"17","author":"Yang","year":"2012","journal-title":"Molecules"},{"key":"10.1016\/j.apsb.2021.08.017_bib211","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3389\/fcimb.2019.00277","article-title":"Lycorine derivative LY-55 inhibits EV71 and CVA16 replication through downregulating autophagy","volume":"9","author":"Wang","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.apsb.2021.08.017_bib212","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077133","article-title":"Heat shock protein 90: role in enterovirus 71 entry and assembly and potential target for therapy","volume":"8","author":"Tsou","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.apsb.2021.08.017_bib213","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006778","article-title":"Prohibitin plays a critical role in Enterovirus 71 neuropathogenesis","volume":"14","author":"Too","year":"2018","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.apsb.2021.08.017_bib214","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.apsb.2014.06.006","article-title":"Curcumin inhibits the replication of enterovirus 71 in\u00a0vitro","volume":"4","author":"Qin","year":"2014","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2021.08.017_bib215","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.apsb.2015.05.005","article-title":"The antiviral and antimicrobial activities of licorice, a widely-used Chinese herb","volume":"5","author":"Wang","year":"2015","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2021.08.017_bib216","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.antiviral.2012.12.010","article-title":"Development and characterization of a stable eGFP enterovirus 71 for antiviral screening","volume":"97","author":"Shang","year":"2013","journal-title":"Antivir Res"},{"key":"10.1016\/j.apsb.2021.08.017_bib217","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jviromet.2015.03.020","article-title":"Development of a stable Gaussia luciferase enterovirus 71 reporter virus","volume":"219","author":"Xu","year":"2015","journal-title":"J Virol Methods"},{"key":"10.1016\/j.apsb.2021.08.017_bib218","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01759-16","article-title":"In vivo imaging with bioluminescent enterovirus 71 allows for real-time visualization of tissue tropism and viral spread","volume":"91","author":"Caine","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.apsb.2021.08.017_bib219","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1073\/pnas.1617363114","article-title":"Enteroviruses infect human enteroids and induce antiviral signaling in a cell lineage-specific manner","volume":"114","author":"Drummond","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2021.08.017_bib220","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3390\/biomedicines9010088","article-title":"Development of three-dimensional human intestinal organoids as a physiologically relevant model for characterizing the viral replication kinetics and antiviral susceptibility of enteroviruses","volume":"9","author":"Tsang","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.apsb.2021.08.017_bib221","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.stemcr.2021.02.009","article-title":"Human intestinal organoids recapitulate enteric infections of enterovirus and coronavirus","volume":"16","author":"Zhao","year":"2021","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.apsb.2021.08.017_bib222","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1086\/375069","article-title":"Efficacy and safety of oral pleconaril for treatment of colds due to picornaviruses in adults: results of 2 double-blind, randomized, placebo-controlled trials","volume":"36","author":"Hayden","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.apsb.2021.08.017_bib223","doi-asserted-by":"crossref","first-page":"5149","DOI":"10.1128\/AAC.00946-12","article-title":"Anti-hepatitis C virus activity and toxicity of type III phosphatidylinositol-4-kinase beta inhibitors","volume":"56","author":"Lamarche","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.apsb.2021.08.017_bib224","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1093\/infdis\/jir174","article-title":"Synergistic inhibition of enterovirus 71 replication by interferon and rupintrivir","volume":"203","author":"Hung","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.apsb.2021.08.017_bib225","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1021\/acs.jmedchem.5b00497","article-title":"Anti-HIV drug discovery and development: current innovations and future trends","volume":"59","author":"Zhan","year":"2016","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2021.08.017_bib226","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1038\/s41564-019-0551-1","article-title":"Enterovirus pathogenesis requires the host methyltransferase SETD3","volume":"4","author":"Diep","year":"2019","journal-title":"Nat Microbiol"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383521003075?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383521003075?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T16:41:43Z","timestamp":1749832903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383521003075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":226,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S2211383521003075"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2021.08.017","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enterovirus A71 antivirals: Past, present, and future","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2021.08.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}